Glutathione trisulfide prevents lipopolysaccharide-induced inflammatory gene expression in retinal pigment epithelial cells
Postmarketing surveillance and observational studies have reported cases of pancreatitis in patients receiving GLP-1 receptor agonists, although a causal relationship remains debated and confounded by underlying disease risk factors ( In addition, rodent studies demonstrating thyroid C-cell hyperplasia and tumors led to class warnings and contraindications in susceptible populations
Effect of PCSK9 monoclonal antibody versus placebo/ezetimibe on atrial fibrillation in patients at high cardiovascular risk: a meta-analysis of 26 randomized controlled trials
Why Hydration Is the Golden Rule If you take a fiber supplement without drinking enough water, you may actually cause more harm than good
Medicare Part D launched the GLP-1 Bridge program on July 1, 2026, covering Wegovy (injection and tablet), Zepbound (KwikPen only), and Foundayo for weight management at $50/month through December 31, 2027